Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)

August 22, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search